Vertex Pharmaceuticals (NASDAQ:VRTX) presented positive long-term data for its gene therapy Casgevy and issued a business ...
Recent research published in the journal “Science Bulletin” detailed the creation of a tool called ChCas12b that can ...
Preliminary data demonstrate that CTX112™ has the potential to provide meaningful clinical benefit with a well-tolerated ...
Kevin Esvelt, an associate professor at the MIT Media Lab and the inventor of CRISPR-based gene drive, joins Radio Boston.
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good ...
New genetic medicines for sickle cell disease were hailed as a milestone. Now researchers are working on ways to widen access ...
CRISPR是一种强大的基因编辑工具,它使用一种名为Cas9的酶对目标基因进行精确编辑。 但问题是,它并不总能留在身体的正确部位,而且在需要的很长时间后仍会继续编辑基因,从而可能引发免疫反应。一种新型癌症基因疗法可以在身体的特定部位远程激活。
A new kind of cancer gene therapy can be remotely activated at a specific part of the body. The team developed a version of ...
The biotech industry has lagged the broader market so far in 2024. The SPDR S&P Biotech ETF, an industry benchmark, is up 9% ...
Ray Kurzweil predicts a future without death by 2029. Discover the science and challenges behind this bold vision for ...
A research group led by Jacob Corn has just discovered that the use of AZD7648 has serious side effects. The study has just ...
The payment scheme will tie gene therapy payments to improvements in health outcomes—and could potentially boost the uptake ...